Records containing: Hyperuricemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-27A Randomized, Open Label, Multicenter, Parallel-group, Positive-controlled, Dose Finding, and Phase II Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects
-
CLINICAL_TRIALS study record update · 2025-01-29A Phase 2, Randomized, Open-Label, Allopurinol-Controlled, Multicenter Study With Two Optional Extensions to Evaluate the Safety and Efficacy of AR882 Alone or in Combination With Allopurinol in Tophaceous Gout Patients
-
CLINICAL_TRIALS study record update · 2025-01-28A Phase 1B Open Label Evaluation of the PK and PD of Dotinurad and Drug-Drug Interaction of Dotinurad and Allopurinol in U.S. Patients with Gout and Hyperuricemia
-
CLINICAL_TRIALS study record update · 2025-01-23Comparative Study Evaluating the Outcome of Febuxostat Versus Vitamin E in Hyperuricemia Patients With Non-alcoholic Steatohepatitis Without Cirrhosis
-
CLINICAL_TRIALS study record update · 2024-12-27Effect of Increased Daily Water Intake in Patients With Hyperuricemia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-11A Phase 1, Open-Label, Parallel-Group, Single-Dose Adaptive Study to Evaluate the Safety and Pharmacokinetics of SAP-001 in Adult Subjects With Normal and Impaired Renal Function
-
CLINICAL_TRIALS study record update · 2024-12-05Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia
-
CLINICAL_TRIALS study record update · 2024-11-12A Randomized, Double-Blind, Placebo-Controlled, Single or Multiple Dose Escalation Study to Evaluate the Safety, PK Profile, PD Profile and Food Effects of SAP-001 Tablets in Healthy Chinese Subjects and Gout Patients With Hyperuricemia
-
CLINICAL_TRIALS study record update · 2024-10-29Possible Pharmacological Effect of Quercetin in the Management of Hyperuricemia
-
CLINICAL_TRIALS study record update · 2024-10-17Potential Pharmacological Effects of Supplemental Quercetin in the Management of Mild to Moderate Hyperuricemia
-
CLINICAL_TRIALS study record update · 2024-10-15A Multicenter Randomized and Controlled Phase IIb Study to Evaluate the Efficacy and Safety of D-0120 Tablets in Patients with Primary Hyperuricemia
-
CLINICAL_TRIALS study record update · 2024-10-03Effects of a Healthy Vegan Diet Vs. Low Purine Diet, with or Without Amla Fruits (Emblica Officinalis) on Hyperuricemia and Other Cardiometabolic Risk Factors: a Randomized Two-by-two Factorial Trial
-
CLINICAL_TRIALS study record update · 2024-09-19A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase II/III Study to Evaluate the Efficacy and Safety of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
-
CLINICAL_TRIALS study record update · 2024-09-19Screening and Management of Hyperuricemia in Patients with Chronic Medical Diseases in Assiut University Hospital
-
CLINICAL_TRIALS study record update · 2024-08-05A Phase 1, Single-center, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Access the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food-effect of FCN-207 in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2024-07-15Effect of 12 Months of Treatment With Continuous Positive Airway Pressure on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea. A Randomized, Open-labell, Parallel Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-07-11A Single-dose, Open-label/Pharmacokinetic and Safety Study of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-01-23Bioequivalence Study of 2 Sizes of SHR4640 Tablets in Healthy Subjects (Randomized, Open, Single Dose, Two Sequences, Two Cycles, Self-Crossover Control)
-
CLINICAL_TRIALS study record update · 2024-01-03A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Multiple Oral Doses of Tigulixostat on the Pharmacokinetics of a Single Oral Dose of Theophylline
-
CLINICAL_TRIALS study record update · 2023-11-07Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2023-10-16A Three Arms, Randomized, Double-blind Controlled Trial of the Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia
-
CLINICAL_TRIALS study record update · 2023-09-07Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)
-
CLINICAL_TRIALS study record update · 2023-08-01Allopurinol Versus Febuxostat: A New Approach for Management of Hepatic Steatosis in Metabolic-Associated Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2023-07-20Probiotics for Gout / Hyperuricemia: A Randomized, Double-blind, Intervention, Parallel Controlled, Multicenter Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-07-03Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid